发明授权
US07700592B2 α2C adrenoreceptor agonists 失效
α2C肾上腺素受体激动剂

α2C adrenoreceptor agonists
摘要:
In its many embodiments, the present invention relates to a novel class of phenylmorpholine and phenylthiomorpholine compounds useful as α2C adrenergic receptor agonists, pharmaceutical compositions containing the compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the α2C adrenergic receptor agonists using such compounds or pharmaceutical compositions.
公开/授权文献
信息查询
0/0